Skip to content

Niagen Bioscience, Inc.

Niagen Bioscience, Inc. completed one sale or spin-off of a business unit disclosed in SEC 8-K filings since January 2025. Each row links to its filing.

1
Units sold
0
Units bought
$0
Disclosed value sold
NAGE
Ticker
Sold

Business units Niagen Bioscience, Inc. sold.

FiledSellerBusiness soldBuyerDisclosed valueSeller sectorFiling
2026-02-26Niagen Bioscience, Inc. (NAGE)ChromaDex Reference Standards business
What the filing says

"Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces the sale of its ChromaDex Reference Standards business to LGC, as of February 24, 2026, in an all-cash transaction."

LGCNot disclosedHealthcareSEC 8-K exhibit
Same sector

Other recent divestitures in the tracker.

Carve-out alerts for buyers

Healthcare carve-outs in your inbox every Wednesday.

One email a week with the completed divestitures and spin-offs from SEC 8-K filings that match your sectors and deal size, each with the filing. A private page holds the full history with a CSV. From $1,500 a year.

See the alert feed
For acquirers

Looking to buy carve-outs?

Register your thesis: sectors, size and geography. When a divestiture mandate we take to market fits it, a senior advisor on our team contacts you under NDA. No fee.

Register your thesis
Method

What counts, and where it comes from.

A row is a completed sale or spin-off of a business unit (a business, segment, division or named subsidiary) reported in a Form 8-K filed with the SEC during the month (or, on a weekly page, the ISO week, Monday to Sunday): under Item 2.01, completion of acquisition or disposition of assets, or in a press release attached to the filing that says the sale has closed.

Sales of buildings, loan books or securities are left out, as is the sale of a whole company. Seller, buyer and value come from the filing, and each row keeps a sentence from it and a link to it. Where a filing does not name the buyer or the price, the table says so rather than filling the gap. The sector is the seller's SEC industry code, not the unit's; where the seller has none (a private or foreign parent, named in a filing made by the buyer), it is the sector of the business sold.

Weekly pages start in September 2026. The months from January 2025 to April 2026, and some deals in later months, were added in October 2026 from every Item 2.01 filing in that window, read and classified by hand rather than by the weekly search. Deals a seller reported only in a quarterly results release or another press release were read and added by hand as well.

Source: SEC EDGAR full-text search and the filings themselves. Public filings only. None of these transactions is one of our mandates, and nothing here is advice.

Planning a carve-out of your own?

The filings show what closed. The work that decides the price happens months earlier: the perimeter, the standalone numbers and the transition services.

Confidential inquiry

Every mandate startswith one conversation.

Tell us what you are considering. A senior advisor on our team will come back with a straight read on value, timing and who would actually buy it, before you commit to anything.

  • Confidential. Nothing you share leaves the advisory team.
  • Success-based. No retainer, no upfront fees, no obligation.
  • A senior advisor on our team responds within one business day.

We never sell or rent lists, and we do not add you to a marketing list without asking. With your consent we pass your enquiry to the team that will handle it.